STOCKHOLM, Sweden, 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company SVF Vaccines has appointed Dr Gaston Picchio as acting CEO. He will ...
KDEV) today publishes its Interim Report - January-September 2024. The full report is available on the Company's website. “Research progress is an important element and one that generates value in our ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued ...
PHILADELPHIA, Nov. 15, 2024 /PRNewswire/ -- Immunovia (NASDAQ Stockholm: IMMNOV), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of ...
The board of Enea AB has appointed Teemu Salmi as the new President and CEO, with starting date April 1, 2025. Teemu Salmi joins from Nordic cybersecurity provider Nixu Corporation, which he joined as ...
Total payment volume increased by 6% to SEK 2,922 million (2,757)Operating income increased by 2% to SEK 96.1 million (94.0)Adjusted operating expenses were SEK ...
GARO has recruited Jonas Klarén as its new President and CEO. Jonas Klarén's most recent position was as CEO of Infratek Sverige AB, which is part of the French VINCI Group, listed on the Paris Stock ...
AAK, one of the world’s leading ingredient suppliers specializing in value-adding specialty fats and oils, recently announced ...
JULY 1 - SEPTEMBER 30, 2024 Group net sales amounted to SEK 285.1 million (262.1), an increase of 8.8 percent. Currency-neutral, net sales increased by 10.4 percent.Net sales for own e-commerce increa ...
Zehetner (Prof. USC) on first 40 patients published in prestigious Swiss Medical Weekly (featuring IEM and large hernia patients) Implantica is listed on Nasdaq First North Premier Growth Market in ...
Today, Safello Group AB ("Safello") publishes the company's interim report for the third quarter (1 July-30 September) 2024. The report is attached hereto and can be found ...
Besqab AB's (publ) ("Besqab") interim report for January - September 2024 shows a stable third quarter with increased sales, higher revenue and improved results, compared to both the previous quarter ...